nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—F10—prostate gland—urinary bladder cancer	0.00666	0.33	CbGeAlD
Fondaparinux sodium—F10—urethra—urinary bladder cancer	0.00446	0.221	CbGeAlD
Fondaparinux sodium—F10—female reproductive system—urinary bladder cancer	0.00363	0.18	CbGeAlD
Fondaparinux sodium—F10—vagina—urinary bladder cancer	0.00329	0.163	CbGeAlD
Fondaparinux sodium—F10—lymph node—urinary bladder cancer	0.00213	0.105	CbGeAlD
Fondaparinux sodium—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000739	0.000754	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000735	0.00075	CcSEcCtD
Fondaparinux sodium—Renal failure—Methotrexate—urinary bladder cancer	0.000733	0.000748	CcSEcCtD
Fondaparinux sodium—Dizziness—Thiotepa—urinary bladder cancer	0.000731	0.000746	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000729	0.000744	CcSEcCtD
Fondaparinux sodium—Urticaria—Fluorouracil—urinary bladder cancer	0.000726	0.000741	CcSEcCtD
Fondaparinux sodium—Dysphagia—Doxorubicin—urinary bladder cancer	0.000724	0.000739	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000722	0.000737	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000714	0.000729	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Etoposide—urinary bladder cancer	0.000713	0.000727	CcSEcCtD
Fondaparinux sodium—Haematuria—Methotrexate—urinary bladder cancer	0.000711	0.000725	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Etoposide—urinary bladder cancer	0.000708	0.000722	CcSEcCtD
Fondaparinux sodium—Somnolence—Etoposide—urinary bladder cancer	0.000706	0.00072	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000705	0.000719	CcSEcCtD
Fondaparinux sodium—Epistaxis—Methotrexate—urinary bladder cancer	0.000703	0.000718	CcSEcCtD
Fondaparinux sodium—Vomiting—Thiotepa—urinary bladder cancer	0.000703	0.000717	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Epirubicin—urinary bladder cancer	0.000698	0.000712	CcSEcCtD
Fondaparinux sodium—Infestation—Epirubicin—urinary bladder cancer	0.000698	0.000712	CcSEcCtD
Fondaparinux sodium—Rash—Thiotepa—urinary bladder cancer	0.000697	0.000711	CcSEcCtD
Fondaparinux sodium—Bronchitis—Doxorubicin—urinary bladder cancer	0.000696	0.000711	CcSEcCtD
Fondaparinux sodium—Dermatitis—Thiotepa—urinary bladder cancer	0.000696	0.00071	CcSEcCtD
Fondaparinux sodium—Headache—Thiotepa—urinary bladder cancer	0.000692	0.000706	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Etoposide—urinary bladder cancer	0.00069	0.000704	CcSEcCtD
Fondaparinux sodium—Renal failure—Epirubicin—urinary bladder cancer	0.000686	0.0007	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000685	0.000699	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Cisplatin—urinary bladder cancer	0.000685	0.000699	CcSEcCtD
Fondaparinux sodium—Fatigue—Etoposide—urinary bladder cancer	0.000684	0.000698	CcSEcCtD
Fondaparinux sodium—Pain—Etoposide—urinary bladder cancer	0.000679	0.000693	CcSEcCtD
Fondaparinux sodium—Constipation—Etoposide—urinary bladder cancer	0.000679	0.000693	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000678	0.000692	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000673	0.000687	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Methotrexate—urinary bladder cancer	0.000673	0.000686	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Methotrexate—urinary bladder cancer	0.000669	0.000683	CcSEcCtD
Fondaparinux sodium—Asthenia—Gemcitabine—urinary bladder cancer	0.000667	0.000681	CcSEcCtD
Fondaparinux sodium—Haematuria—Epirubicin—urinary bladder cancer	0.000665	0.000679	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.00066	0.000673	CcSEcCtD
Fondaparinux sodium—Epistaxis—Epirubicin—urinary bladder cancer	0.000658	0.000672	CcSEcCtD
Fondaparinux sodium—Pruritus—Gemcitabine—urinary bladder cancer	0.000658	0.000671	CcSEcCtD
Fondaparinux sodium—Nausea—Thiotepa—urinary bladder cancer	0.000656	0.00067	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Etoposide—urinary bladder cancer	0.000654	0.000668	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000649	0.000662	CcSEcCtD
Fondaparinux sodium—Pruritus—Fluorouracil—urinary bladder cancer	0.000647	0.00066	CcSEcCtD
Fondaparinux sodium—Infestation—Doxorubicin—urinary bladder cancer	0.000645	0.000659	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000645	0.000659	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000638	0.000651	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000636	0.000649	CcSEcCtD
Fondaparinux sodium—Renal failure—Doxorubicin—urinary bladder cancer	0.000634	0.000648	CcSEcCtD
Fondaparinux sodium—Urticaria—Etoposide—urinary bladder cancer	0.000631	0.000644	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Epirubicin—urinary bladder cancer	0.000629	0.000642	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Etoposide—urinary bladder cancer	0.000627	0.00064	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Etoposide—urinary bladder cancer	0.000627	0.00064	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000627	0.00064	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Epirubicin—urinary bladder cancer	0.000626	0.000639	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000625	0.000638	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000623	0.000636	CcSEcCtD
Fondaparinux sodium—Asthenia—Cisplatin—urinary bladder cancer	0.000622	0.000634	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000617	0.00063	CcSEcCtD
Fondaparinux sodium—Haematuria—Doxorubicin—urinary bladder cancer	0.000615	0.000628	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.00061	0.000623	CcSEcCtD
Fondaparinux sodium—Epistaxis—Doxorubicin—urinary bladder cancer	0.000609	0.000621	CcSEcCtD
Fondaparinux sodium—Angiopathy—Methotrexate—urinary bladder cancer	0.000607	0.00062	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Methotrexate—urinary bladder cancer	0.000604	0.000617	CcSEcCtD
Fondaparinux sodium—Dizziness—Fluorouracil—urinary bladder cancer	0.000604	0.000617	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000603	0.000615	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Cisplatin—urinary bladder cancer	0.000593	0.000605	CcSEcCtD
Fondaparinux sodium—Vomiting—Gemcitabine—urinary bladder cancer	0.000591	0.000603	CcSEcCtD
Fondaparinux sodium—Rash—Gemcitabine—urinary bladder cancer	0.000586	0.000598	CcSEcCtD
Fondaparinux sodium—Dermatitis—Gemcitabine—urinary bladder cancer	0.000586	0.000598	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Etoposide—urinary bladder cancer	0.000585	0.000597	CcSEcCtD
Fondaparinux sodium—Malnutrition—Methotrexate—urinary bladder cancer	0.000583	0.000595	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000582	0.000594	CcSEcCtD
Fondaparinux sodium—Headache—Gemcitabine—urinary bladder cancer	0.000582	0.000594	CcSEcCtD
Fondaparinux sodium—Flushing—Epirubicin—urinary bladder cancer	0.000581	0.000593	CcSEcCtD
Fondaparinux sodium—Vomiting—Fluorouracil—urinary bladder cancer	0.000581	0.000593	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000579	0.000591	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000577	0.000588	CcSEcCtD
Fondaparinux sodium—Rash—Fluorouracil—urinary bladder cancer	0.000576	0.000588	CcSEcCtD
Fondaparinux sodium—Dermatitis—Fluorouracil—urinary bladder cancer	0.000576	0.000588	CcSEcCtD
Fondaparinux sodium—Headache—Fluorouracil—urinary bladder cancer	0.000573	0.000584	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000571	0.000583	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Methotrexate—urinary bladder cancer	0.00057	0.000582	CcSEcCtD
Fondaparinux sodium—Asthenia—Etoposide—urinary bladder cancer	0.000569	0.000581	CcSEcCtD
Fondaparinux sodium—Angiopathy—Epirubicin—urinary bladder cancer	0.000568	0.00058	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Epirubicin—urinary bladder cancer	0.000566	0.000577	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000564	0.000576	CcSEcCtD
Fondaparinux sodium—Back pain—Methotrexate—urinary bladder cancer	0.000563	0.000575	CcSEcCtD
Fondaparinux sodium—Pruritus—Etoposide—urinary bladder cancer	0.000562	0.000573	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Epirubicin—urinary bladder cancer	0.000559	0.000571	CcSEcCtD
Fondaparinux sodium—Nausea—Gemcitabine—urinary bladder cancer	0.000552	0.000563	CcSEcCtD
Fondaparinux sodium—Vomiting—Cisplatin—urinary bladder cancer	0.000551	0.000562	CcSEcCtD
Fondaparinux sodium—Vision blurred—Methotrexate—urinary bladder cancer	0.000549	0.00056	CcSEcCtD
Fondaparinux sodium—Rash—Cisplatin—urinary bladder cancer	0.000546	0.000557	CcSEcCtD
Fondaparinux sodium—Dermatitis—Cisplatin—urinary bladder cancer	0.000546	0.000557	CcSEcCtD
Fondaparinux sodium—Malnutrition—Epirubicin—urinary bladder cancer	0.000545	0.000556	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Etoposide—urinary bladder cancer	0.000543	0.000554	CcSEcCtD
Fondaparinux sodium—Nausea—Fluorouracil—urinary bladder cancer	0.000543	0.000554	CcSEcCtD
Fondaparinux sodium—Anaemia—Methotrexate—urinary bladder cancer	0.000538	0.000549	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—urinary bladder cancer	0.000538	0.000549	CcSEcCtD
Fondaparinux sodium—Flatulence—Epirubicin—urinary bladder cancer	0.000537	0.000548	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Epirubicin—urinary bladder cancer	0.000534	0.000545	CcSEcCtD
Fondaparinux sodium—Back pain—Epirubicin—urinary bladder cancer	0.000527	0.000538	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—urinary bladder cancer	0.000526	0.000537	CcSEcCtD
Fondaparinux sodium—Dizziness—Etoposide—urinary bladder cancer	0.000525	0.000536	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000523	0.000534	CcSEcCtD
Fondaparinux sodium—Vertigo—Methotrexate—urinary bladder cancer	0.000523	0.000534	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000522	0.000533	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000518	0.000528	CcSEcCtD
Fondaparinux sodium—Nausea—Cisplatin—urinary bladder cancer	0.000515	0.000525	CcSEcCtD
Fondaparinux sodium—Vision blurred—Epirubicin—urinary bladder cancer	0.000514	0.000524	CcSEcCtD
Fondaparinux sodium—Cough—Methotrexate—urinary bladder cancer	0.000508	0.000519	CcSEcCtD
Fondaparinux sodium—Convulsion—Methotrexate—urinary bladder cancer	0.000505	0.000515	CcSEcCtD
Fondaparinux sodium—Vomiting—Etoposide—urinary bladder cancer	0.000505	0.000515	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—urinary bladder cancer	0.000504	0.000515	CcSEcCtD
Fondaparinux sodium—Anaemia—Epirubicin—urinary bladder cancer	0.000504	0.000514	CcSEcCtD
Fondaparinux sodium—Rash—Etoposide—urinary bladder cancer	0.0005	0.000511	CcSEcCtD
Fondaparinux sodium—Dermatitis—Etoposide—urinary bladder cancer	0.0005	0.00051	CcSEcCtD
Fondaparinux sodium—Headache—Etoposide—urinary bladder cancer	0.000497	0.000507	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—urinary bladder cancer	0.000497	0.000507	CcSEcCtD
Fondaparinux sodium—Chest pain—Methotrexate—urinary bladder cancer	0.000496	0.000506	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000494	0.000504	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000493	0.000503	CcSEcCtD
Fondaparinux sodium—Vertigo—Epirubicin—urinary bladder cancer	0.00049	0.0005	CcSEcCtD
Fondaparinux sodium—Syncope—Epirubicin—urinary bladder cancer	0.000489	0.000499	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—urinary bladder cancer	0.000488	0.000498	CcSEcCtD
Fondaparinux sodium—Palpitations—Epirubicin—urinary bladder cancer	0.000482	0.000492	CcSEcCtD
Fondaparinux sodium—Confusional state—Methotrexate—urinary bladder cancer	0.000479	0.000489	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000479	0.000489	CcSEcCtD
Fondaparinux sodium—Cough—Epirubicin—urinary bladder cancer	0.000476	0.000485	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000475	0.000485	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—urinary bladder cancer	0.000475	0.000485	CcSEcCtD
Fondaparinux sodium—Convulsion—Epirubicin—urinary bladder cancer	0.000472	0.000482	CcSEcCtD
Fondaparinux sodium—Infection—Methotrexate—urinary bladder cancer	0.000472	0.000482	CcSEcCtD
Fondaparinux sodium—Nausea—Etoposide—urinary bladder cancer	0.000471	0.000481	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000466	0.000476	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—urinary bladder cancer	0.000466	0.000476	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000465	0.000475	CcSEcCtD
Fondaparinux sodium—Chest pain—Epirubicin—urinary bladder cancer	0.000464	0.000474	CcSEcCtD
Fondaparinux sodium—Anxiety—Epirubicin—urinary bladder cancer	0.000463	0.000472	CcSEcCtD
Fondaparinux sodium—Skin disorder—Methotrexate—urinary bladder cancer	0.000462	0.000471	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000461	0.00047	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00046	0.000469	CcSEcCtD
Fondaparinux sodium—Vertigo—Doxorubicin—urinary bladder cancer	0.000453	0.000463	CcSEcCtD
Fondaparinux sodium—Anorexia—Methotrexate—urinary bladder cancer	0.000453	0.000462	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—urinary bladder cancer	0.000452	0.000462	CcSEcCtD
Fondaparinux sodium—Confusional state—Epirubicin—urinary bladder cancer	0.000449	0.000458	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—urinary bladder cancer	0.000446	0.000455	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000445	0.000454	CcSEcCtD
Fondaparinux sodium—Oedema—Epirubicin—urinary bladder cancer	0.000445	0.000454	CcSEcCtD
Fondaparinux sodium—Hypotension—Methotrexate—urinary bladder cancer	0.000444	0.000453	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000443	0.000452	CcSEcCtD
Fondaparinux sodium—Infection—Epirubicin—urinary bladder cancer	0.000442	0.000451	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—urinary bladder cancer	0.00044	0.000449	CcSEcCtD
Fondaparinux sodium—Shock—Epirubicin—urinary bladder cancer	0.000438	0.000447	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—urinary bladder cancer	0.000437	0.000446	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000436	0.000445	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000436	0.000445	CcSEcCtD
Fondaparinux sodium—Tachycardia—Epirubicin—urinary bladder cancer	0.000434	0.000443	CcSEcCtD
Fondaparinux sodium—Skin disorder—Epirubicin—urinary bladder cancer	0.000432	0.000441	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00043	0.000439	CcSEcCtD
Fondaparinux sodium—Insomnia—Methotrexate—urinary bladder cancer	0.00043	0.000439	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—urinary bladder cancer	0.000429	0.000438	CcSEcCtD
Fondaparinux sodium—Anxiety—Doxorubicin—urinary bladder cancer	0.000428	0.000437	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Methotrexate—urinary bladder cancer	0.000427	0.000436	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000426	0.000435	CcSEcCtD
Fondaparinux sodium—Anorexia—Epirubicin—urinary bladder cancer	0.000424	0.000433	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Methotrexate—urinary bladder cancer	0.000424	0.000433	CcSEcCtD
Fondaparinux sodium—Somnolence—Methotrexate—urinary bladder cancer	0.000423	0.000431	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Methotrexate—urinary bladder cancer	0.000418	0.000427	CcSEcCtD
Fondaparinux sodium—Hypotension—Epirubicin—urinary bladder cancer	0.000416	0.000424	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—urinary bladder cancer	0.000415	0.000424	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Methotrexate—urinary bladder cancer	0.000413	0.000422	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000412	0.00042	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—urinary bladder cancer	0.000412	0.00042	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00041	0.000419	CcSEcCtD
Fondaparinux sodium—Fatigue—Methotrexate—urinary bladder cancer	0.00041	0.000418	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—urinary bladder cancer	0.000409	0.000417	CcSEcCtD
Fondaparinux sodium—Pain—Methotrexate—urinary bladder cancer	0.000407	0.000415	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—urinary bladder cancer	0.000405	0.000413	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000404	0.000412	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000403	0.000411	CcSEcCtD
Fondaparinux sodium—Insomnia—Epirubicin—urinary bladder cancer	0.000402	0.000411	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—urinary bladder cancer	0.000402	0.00041	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—urinary bladder cancer	0.0004	0.000408	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Epirubicin—urinary bladder cancer	0.0004	0.000408	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000398	0.000406	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Epirubicin—urinary bladder cancer	0.000397	0.000405	CcSEcCtD
Fondaparinux sodium—Somnolence—Epirubicin—urinary bladder cancer	0.000396	0.000404	CcSEcCtD
Fondaparinux sodium—Anorexia—Doxorubicin—urinary bladder cancer	0.000392	0.0004	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000392	0.0004	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Epirubicin—urinary bladder cancer	0.000392	0.0004	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000389	0.000397	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Epirubicin—urinary bladder cancer	0.000387	0.000395	CcSEcCtD
Fondaparinux sodium—Hypotension—Doxorubicin—urinary bladder cancer	0.000385	0.000393	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000384	0.000392	CcSEcCtD
Fondaparinux sodium—Fatigue—Epirubicin—urinary bladder cancer	0.000384	0.000391	CcSEcCtD
Fondaparinux sodium—Pain—Epirubicin—urinary bladder cancer	0.00038	0.000388	CcSEcCtD
Fondaparinux sodium—Constipation—Epirubicin—urinary bladder cancer	0.00038	0.000388	CcSEcCtD
Fondaparinux sodium—Urticaria—Methotrexate—urinary bladder cancer	0.000378	0.000385	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Methotrexate—urinary bladder cancer	0.000376	0.000384	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Methotrexate—urinary bladder cancer	0.000376	0.000384	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—urinary bladder cancer	0.000372	0.00038	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00037	0.000377	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000367	0.000375	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000367	0.000374	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—urinary bladder cancer	0.000366	0.000373	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000364	0.000371	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000362	0.00037	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000358	0.000365	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000355	0.000363	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—urinary bladder cancer	0.000355	0.000362	CcSEcCtD
Fondaparinux sodium—Urticaria—Epirubicin—urinary bladder cancer	0.000353	0.000361	CcSEcCtD
Fondaparinux sodium—Pain—Doxorubicin—urinary bladder cancer	0.000352	0.000359	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—urinary bladder cancer	0.000352	0.000359	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Epirubicin—urinary bladder cancer	0.000352	0.000359	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Epirubicin—urinary bladder cancer	0.000352	0.000359	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00035	0.000357	CcSEcCtD
Fondaparinux sodium—Asthenia—Methotrexate—urinary bladder cancer	0.000341	0.000348	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000339	0.000346	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000337	0.000344	CcSEcCtD
Fondaparinux sodium—Pruritus—Methotrexate—urinary bladder cancer	0.000336	0.000343	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000328	0.000335	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—urinary bladder cancer	0.000327	0.000334	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000325	0.000332	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000325	0.000332	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Methotrexate—urinary bladder cancer	0.000325	0.000332	CcSEcCtD
Fondaparinux sodium—Asthenia—Epirubicin—urinary bladder cancer	0.000319	0.000326	CcSEcCtD
Fondaparinux sodium—Pruritus—Epirubicin—urinary bladder cancer	0.000315	0.000321	CcSEcCtD
Fondaparinux sodium—Dizziness—Methotrexate—urinary bladder cancer	0.000314	0.000321	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Epirubicin—urinary bladder cancer	0.000304	0.000311	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000303	0.00031	CcSEcCtD
Fondaparinux sodium—Vomiting—Methotrexate—urinary bladder cancer	0.000302	0.000308	CcSEcCtD
Fondaparinux sodium—Rash—Methotrexate—urinary bladder cancer	0.0003	0.000306	CcSEcCtD
Fondaparinux sodium—Dermatitis—Methotrexate—urinary bladder cancer	0.000299	0.000306	CcSEcCtD
Fondaparinux sodium—Headache—Methotrexate—urinary bladder cancer	0.000298	0.000304	CcSEcCtD
Fondaparinux sodium—Asthenia—Doxorubicin—urinary bladder cancer	0.000295	0.000301	CcSEcCtD
Fondaparinux sodium—Dizziness—Epirubicin—urinary bladder cancer	0.000294	0.0003	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—urinary bladder cancer	0.000291	0.000297	CcSEcCtD
Fondaparinux sodium—Vomiting—Epirubicin—urinary bladder cancer	0.000283	0.000289	CcSEcCtD
Fondaparinux sodium—Nausea—Methotrexate—urinary bladder cancer	0.000282	0.000288	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000282	0.000287	CcSEcCtD
Fondaparinux sodium—Rash—Epirubicin—urinary bladder cancer	0.000281	0.000286	CcSEcCtD
Fondaparinux sodium—Dermatitis—Epirubicin—urinary bladder cancer	0.00028	0.000286	CcSEcCtD
Fondaparinux sodium—Headache—Epirubicin—urinary bladder cancer	0.000279	0.000284	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—urinary bladder cancer	0.000272	0.000278	CcSEcCtD
Fondaparinux sodium—Nausea—Epirubicin—urinary bladder cancer	0.000264	0.00027	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—urinary bladder cancer	0.000262	0.000267	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—urinary bladder cancer	0.00026	0.000265	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—urinary bladder cancer	0.000259	0.000265	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—urinary bladder cancer	0.000258	0.000263	CcSEcCtD
Fondaparinux sodium—Nausea—Doxorubicin—urinary bladder cancer	0.000245	0.00025	CcSEcCtD
